Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-5
SponsorKonya City Hospital
About this trial
This study aims to investigate the relationship between the method of surfactant administration and improvements in serial lung ultrasound findings in preterm infants requiring surfactant therapy.
Eligibility criteria
Qualifiers
Infants of families who agree to participate in the study
Preterm infants born before 32 weeks of gestation requiring surfactant therapy due to an RDS diagnosis.
Disqualifiers
Infants whose families did not provide consent
Infants with a syndromic appearance or congenital heart disease
Preterm infants born after 32 weeks of gestation
Trial design
Treatments tested in this trial
- Evaluation of serial lung ultrasound data after ENSURE surfactant treatments
- Evaluation of serial lung ultrasound data after LISA surfactant treatments
Treatment groups
68 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov